| Schedule of results by segment |
| | | | | | | | | | | | | | | | | | | Quarter Ended | | Nine Months Ended | | May 29, 2025 | May 30, 2024 | | May 29, 2025 | May 30, 2024 | | | | | | | | Revenue | | | | | | | CNBU | $ | 5,069 | | $ | 2,573 | | | $ | 14,028 | | $ | 6,495 | | | SBU | 1,451 | | 1,353 | | | 4,574 | | 2,911 | | | MBU | 1,551 | | 1,588 | | | 4,146 | | 4,479 | | | EBU | 1,227 | | 1,294 | | | 3,304 | | 3,442 | | All other | 3 | | 3 | | | 11 | | 34 | | Total revenue | $ | 9,301 | | $ | 6,811 | | | $ | 26,063 | | $ | 17,361 | | | | | | | | | Operating income (loss) | | | | | | | CNBU | $ | 2,182 | | $ | 442 | | | $ | 5,812 | | $ | 73 | | | SBU | (9) | | 76 | | | 362 | | (631) | | | MBU | 217 | | 301 | | | 604 | | (395) | | | EBU | 98 | | 124 | | | 112 | | 133 | | All other | 2 | | (2) | | | 1 | | 23 | | | 2,490 | | 941 | | | 6,891 | | (797) | | | | | | | | | Unallocated | | | | | | | Stock-based compensation | (263) | | (217) | | | (713) | | (608) | | | Patent license charges | (57) | | — | | | (57) | | — | | | Lower costs from sale of inventory written down in prior periods | — | | — | | | — | | 987 | | | Patent cross-license agreement gain | — | | — | | | — | | 200 | | | Other | (1) | | (5) | | | (5) | | — | | | (321) | | (222) | | | (775) | | 579 | | | | | | | | Total operating income (loss) | $ | 2,169 | | $ | 719 | | | $ | 6,116 | | $ | (218) | |
|